"Global Cell-Based Immunotherapy Market - Industry Trends and Forecast to 2028
Global Cell-Based Immunotherapy Market, By Application (Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Other), End User (Hospitals, Ambulatory Surgical Centers, Specialized Cancer Institutes), and Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of the Middle East Africa) Industry Trends and Forecast to 2028
The cell-based immunotherapy market is expected to witness market growth at a rate of 19.01% in the forecast period of 2021 to 2028. Data Bridge Market Research report on cell-based immunotherapy market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the number of clinical studies for cell-based therapies is escalating the growth of cell-based immunotherapy market.
Access Full 350 Pages PDF Report @
https://www.databridgemarketresearch.com/reports/global-cell-based-immunotherapy-market
**Segments**
- **Cell Type**:
- T-Cells
- Dendritic Cells
- Natural Killer (NK) Cells
- Macrophages
- **Therapy**:
- CAR-T Cell Therapy
- T-Cell Receptor (TCR) Therapy
- Adoptive Cell Transfer (ACT)
- Tumor-Infiltrating Lymphocytes (TILs) Therapy
- **Application**:
- Oncology
- Autoimmune Diseases
- Infectious Diseases
- Others
**Market Players**
- **Novartis International AG**:
- Novartis is a key player in the cell-based immunotherapy market, particularly known for its CAR-T cell therapy products, Kymriah and Yescarta. The company has a strong presence in oncology treatments and continues to invest heavily in research and development in the field of cell-based therapies.
- **Gilead Sciences, Inc.**:
- Gilead Sciences made a significant impact on the market with its acquisition of Kite Pharma, a pioneer in CAR-T cell therapy development. Their flagship product, Yescarta, has shown promising results in treating certain types of lymphomas, demonstrating the company's commitment to advancing cell-based immunotherapy.
- **Bristol Myers Squibb (BMS)**:
- BMS is another prominent player in the cell-based immunotherapy market, with a focus on developing immunotherapies for various cancers. The acquisition of Celgene further strengthened BMS's position in the market, broadening its portfolio of cell-based treatment options.
- **Adaptimmune Therapeutics**:
- Adaptimmune specializes in TCR therapy, aiming to harness the power of T cells to target solid tumors. The company's unique approach to cell-based immunotherapy has garnered attention in the industry, positioning it as a key player in the development of innovative cancer treatments.
The global cell-basedThe global cell-based immunotherapy market continues to witness significant growth and advancements with key players at the forefront of driving innovation and development in this sector. Novartis International AG stands out as a leading player with its notable CAR-T cell therapy products, Kymriah and Yescarta, which have been instrumental in the treatment of certain types of cancers. Novartis's strong presence in oncology treatments and ongoing investments in research and development further solidify its position in the cell-based immunotherapy market. The company's commitment to advancing cell-based therapies underscores its dedication to addressing unmet medical needs and improving patient outcomes.
Gilead Sciences, Inc. has made a marked impact on the market through its acquisition of Kite Pharma, a pioneer in CAR-T cell therapy development. The acquisition has enabled Gilead Sciences to expand its portfolio of innovative treatments, with Yescarta showcasing promising results in the treatment of specific lymphomas. The company's strategic focus on advancing cell-based immunotherapy aligns with its goal of delivering breakthrough therapies for patients, thereby driving growth and competitiveness in the market.
Bristol Myers Squibb (BMS) is another key player in the cell-based immunotherapy market, with a strong emphasis on developing immunotherapies for various cancers. The acquisition of Celgene has further enhanced BMS's position in the market, empowering the company to offer a diverse range of cell-based treatment options to patients. BMS's continued efforts in research and development underscore its commitment to driving innovation and improving treatment outcomes in oncology and other disease areas.
Adaptimmune Therapeutics has emerged as a notable player in the cell-based immunotherapy market, specializing in TCR therapy to target solid tumors effectively. The company's unique approach to leveraging T cells in cancer treatment has positioned it as a key innovator in developing cutting-edge therapies. Adaptimmune's focus on harnessing the power of the immune system to combat cancer reflects the growing trend towards personalized and targeted treatments in the field of cell**Global Cell-Based Immunotherapy Market Overview**
The global cell-based immunotherapy market is experiencing substantial growth, driven by the increasing prevalence of cancer and autoimmune diseases, coupled with advancements in cell therapy technologies. The market is segmented based on cell type, therapy, and application, with key players like Novartis International AG, Gilead Sciences, Inc., Bristol Myers Squibb (BMS), and Adaptimmune Therapeutics leading the way in innovative treatment solutions.
**Segments**
- **Cell Type**: The market encompasses various cell types such as T-cells, dendritic cells, natural killer (NK) cells, and macrophages, each playing a unique role in immune response and therapy development.
- **Therapy**: Cell-based therapies like CAR-T cell therapy, T-cell receptor (TCR) therapy, adoptive cell transfer (ACT), and tumor-infiltrating lymphocytes (TILs) therapy are gaining traction for their efficacy in treating cancer, autoimmune diseases, and infectious conditions.
- **Application**: Cell-based immunotherapy finds application in oncology, autoimmune diseases, infectious diseases, and other therapeutic areas, offering personalized and targeted treatment options for patients.
**Market Players Analysis**
Novartis International AG remains a prominent player in the cell-based immunotherapy market, known for its pioneering CAR-T cell therapy products, Kymriah and Yescarta. The company's strong focus on oncology treatments and continued investment in research and development underscore its commitment to advancing cell-based
Cell-Based Immunotherapy Key Benefits over Global Competitors:
- The report provides a qualitative and quantitative analysis of the Cell-Based Immunotherapy Market trends, forecasts, and market size to determine new opportunities.
- Porter’s Five Forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make strategic business decisions and determine the level of competition in the industry.
- Top impacting factors major investment pockets are highlighted in the research.
- The major countries in each region are analyzed and their revenue contribution is mentioned.
- The market player positioning segment provides an understanding of the current position of the market players active in the Personal Care Ingredients
Table of Contents: Cell-Based Immunotherapy Market
1 Introduction
2 Market Segmentation
3 Executive Summary
4 Premium Insight
5 Market Overview
6 Cell-Based Immunotherapy Market, by Product Type
7 Cell-Based Immunotherapy Market, by Modality
8 Cell-Based Immunotherapy Market, by Type
9 Cell-Based Immunotherapy Market, by Mode
10 Cell-Based Immunotherapy Market, by End User
12 Cell-Based Immunotherapy Market, by Geography
12 Cell-Based Immunotherapy Market, Company Landscape
13 Swot Analysis
14 Company Profiles
The investment made in the study would provide you access to information such as:
- Cell-Based Immunotherapy Market [Global – Broken-down into regions]
- Regional level split [North America, Europe, Asia Pacific, South America, Middle East Africa]
- Country wise Market Size Split [of important countries with major market share]
- Market Share and Revenue/Sales by leading players
- Market Trends – Emerging Technologies/products/start-ups, PESTEL Analysis, SWOT Analysis, Porter’s Five Forces, etc.
- Market Size)
- Market Size by application/industry verticals
- Market Projections/Forecast
Critical Insights Related to the Cell-Based Immunotherapy Included in the Report:
- Exclusive graphics and Illustrative Porter’s Five Forces analysis of some of the leading companies in this market
- Value chain analysis of prominent players in the market
- Current trends influencing the dynamics of this market across various geographies
- Recent mergers, acquisitions, collaborations, and partnerships
- Revenue growth of this industry over the forecast period
- Marketing strategy study and growth trends
- Growth-driven factor analysis
- Emerging recess segments and region-wise market
- An empirical evaluation of the curve of this market
- Ancient, Present, and Probable scope of the market from both prospect value and volume
Browse Trending Reports:
Nutritional Food Market
Blowing Agents Market
Wood Adhesives Market
Gaur Gum Market
Swine Respiratory Diseases Treatment Market
Blood Warmer Devices Sample Warmer Market
Lutein Market
Refinish Paint Market
Dental Membrane Bone Graft Substitute Market
Location Analytics Market
Chatbots Market
Amaranth Oil Market
Polyols Market
Refrigeration Oil Market
Glycinates Market
Postoperative Management Market
Variable Air Volume Systems Market
Chitosan Market
Textile Dyes Market
Ambulatory Emr Market
Low Rolling Resistance Tires Market
Telemetry Market
Micro Led Market
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 975
